tradingkey.logo
tradingkey.logo
Search

Basilea Receives Additional USD 6 Million Funding From Carb-X

ReutersApr 9, 2026 5:19 AM
facebooktwitterlinkedin

- Basilea Pharmaceutica AG Allschwil BSLN.S:

  • RECEIVES ADDITIONAL USD 6 MILLION FUNDING FROM CARB-X

  • FUNDING TO SUPPORT FIRST-IN-HUMAN PHASE 1 STUDY OF BAL2420

  • BASILEA PHARMACEUTICA - FIRST SUBJECT DOSED IN PHASE 1 STUDY OF BAL2420 IN MARCH 2026

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Recommended Articles

Tradingkey
KeyAI